Literature DB >> 4062971

Characteristics of the cytotoxic effects of the phenothiazine class of calmodulin antagonists.

W N Hait, G L Lee.   

Abstract

We have characterized the antiproliferative effects of the phenothiazines, a group of antipsychotic drugs possessing a wide range of pharmacological actions. The phenothiazines inhibited both the proliferation and clonogenicity of L1210 leukemic lymphocytes. This effect was dependent on both time of exposure and concentration of drug. Clonogenicity of cells in the logarithmic phase of growth was inhibited by greater than 99% at a concentration of drug that had no effect on cells in the plateau phase of growth. Human and murine cell lines, grown either in suspension or in monolayers, were equally susceptible. Calmodulin (CaM), purified from L1210 cells by preparative polyacrylamide gel electrophoresis, had sensitivity to inhibition by phenothiazines similar to that reported for CaM prepared from brain. The order of potency was trifluoperazine greater than or equal to fluphenazine greater than chlorpromazine greater than chlorpromazine-sulfoxide. As a class, these drugs were less potent antagonists of CaM than was the bee venom polypeptide, melittin. The antiproliferative effects of phenothiazines were similar to the anticalmodulin effects. Thus, the same order of potencies was seen for both effects; the shapes of the dose-response curves were similarly steep and the effects of excess calcium on the inhibition of both were identical. These studies add pharmacological support for CaM being a potential intracellular target for the antiproliferative effect of the phenothiazines.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4062971     DOI: 10.1016/0006-2952(85)90374-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  12 in total

1.  Phase I trial of combined therapy with bleomycin and the calmodulin antagonist, trifluoperazine.

Authors:  W N Hait; S Morris; J S Lazo; R J Figlin; H J Durivage; K White; P E Schwartz
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Reversal of multidrug resistance in murine fibrosarcoma cells by thioxanthene flupentixol.

Authors:  D Fan; G Poste; C Seid; L E Earnest; T Bull; R K Clyne; I J Fidler
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

3.  Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K/AKT, ERK, and pertussis toxin-sensitive pathways.

Authors:  Xiao-Hong Lu; Donard S Dwyer
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

4.  Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms.

Authors:  I Gil-ad; B Shtaif; R Shiloh; A Weizman
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

5.  Amiodarone is a potent calmodulin antagonist.

Authors:  P Nokin; J P Blondiaux; P Schaeffer; L Jungbluth; C Lugnier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

6.  Inhibition and Ultraviolet-Induced Chemical Modification of UDP-Glucose:(1,3)-beta-Glucan (Callose) Synthase by Chlorpromazine : Mechanism of Chlorpromazine Binding to the Plant Plasma Membrane.

Authors:  R W Harriman; A P Shao; B P Wasserman
Journal:  Plant Physiol       Date:  1992-12       Impact factor: 8.340

7.  Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines: clinical relevance and possible application for brain-derived tumors.

Authors:  Irit Gil-Ad; Biana Shtaif; Yechiel Levkovitz; Michal Dayag; Ella Zeldich; Abraham Weizman
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 8.  Putative therapeutic applications of calmodulin antagonists.

Authors:  R Mannhold; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

9.  The antiproliferative properties of tamoxifen and phenothiazines may be mediated by a unique histamine receptor (?H3) distinct from the calmodulin-binding site.

Authors:  L J Brandes; R P Bogdanovic; M D Cawker; R Bose
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 10.  Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents.

Authors:  David L Brautigan; Caroline Farrington; Goutham Narla
Journal:  Clin Sci (Lond)       Date:  2021-07-16       Impact factor: 6.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.